Swedencare (SECARE) Stock Overview
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
SECARE Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
Swedencare AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 23.55 |
| 52 Week High | SEK 49.25 |
| 52 Week Low | SEK 22.40 |
| Beta | 0.60 |
| 1 Month Change | -1.26% |
| 3 Month Change | -37.53% |
| 1 Year Change | -39.30% |
| 3 Year Change | -7.54% |
| 5 Year Change | -74.68% |
| Change since IPO | 554.17% |
Recent News & Updates
Online And Pharma Execution Risks Will Test Pet Health Upside Potential
Catalysts About Swedencare Swedencare develops and sells pet health products across dental care, nutraceuticals, treats and veterinary pharma, with a growing focus on online and Big Box retail channels. What are the underlying business or industry changes driving this perspective?Swedencare AB (publ) Just Missed EPS By 9.9%: Here's What Analysts Think Will Happen Next
Feb 15
Recent updates
Online And Pharma Execution Risks Will Test Pet Health Upside Potential
Catalysts About Swedencare Swedencare develops and sells pet health products across dental care, nutraceuticals, treats and veterinary pharma, with a growing focus on online and Big Box retail channels. What are the underlying business or industry changes driving this perspective?Swedencare AB (publ) Just Missed EPS By 9.9%: Here's What Analysts Think Will Happen Next
Feb 15
The Compound Effect: From Acquisition to Integration
In 2026, the story is no longer about how many companies Swedencare can buy, but how effectively it can scale its existing brands (ProDen PlaqueOff and NaturVet) into global Big Box retail and e-commerce The Pet Humanization Play Swedencare's narrative rests on three pillars: The Global Brand Portfolio: Moving from a single product company to a diversified pet health giant. The story is about cross-selling, taking a successful dental product from Sweden and putting it in 2,000 Walmart stores in the US The Channel Pivot: Swedencare is taking direct control of its destiny by moving Amazon sales inhouse and entering Big Box retail like Walmart, CVS etc.
Big Box Expansion And Soft Chew Capacity Will Transform Long Term Pet Health Prospects
Catalysts About Swedencare Swedencare develops and sells pet health products and provides contract development and manufacturing services to animal health companies. What are the underlying business or industry changes driving this perspective?With A 37% Price Drop For Swedencare AB (publ) (STO:SECARE) You'll Still Get What You Pay For
Feb 01We Think Swedencare's (STO:SECARE) Solid Earnings Are Understated
Oct 30Swedencare AB (publ) Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Jul 26
Resolving NaturVet's Challenges And Global Expansion Will Enhance Future Opportunities
Improved growth strategy for NaturVet and global market expansion aim to enhance revenue and achieve group targets.Does Swedencare (STO:SECARE) Deserve A Spot On Your Watchlist?
Apr 29Shareholder Returns
| SECARE | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | -0.6% | -0.1% | -0.4% |
| 1Y | -39.3% | -22.9% | 2.5% |
Return vs Industry: SECARE underperformed the Swedish Pharmaceuticals industry which returned -22.9% over the past year.
Return vs Market: SECARE underperformed the Swedish Market which returned 2.5% over the past year.
Price Volatility
| SECARE volatility | |
|---|---|
| SECARE Average Weekly Movement | 10.0% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in SE Market | 12.6% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: SECARE's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: SECARE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 613 | Hakan Lagerberg | www.swedencare.com |
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care products, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name.
Swedencare AB (publ) Fundamentals Summary
| SECARE fundamental statistics | |
|---|---|
| Market cap | SEK 3.79b |
| Earnings (TTM) | SEK 55.50m |
| Revenue (TTM) | SEK 2.69b |
Is SECARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SECARE income statement (TTM) | |
|---|---|
| Revenue | SEK 2.69b |
| Cost of Revenue | SEK 1.13b |
| Gross Profit | SEK 1.57b |
| Other Expenses | SEK 1.51b |
| Earnings | SEK 55.50m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 02, 2026
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 58.24% |
| Net Profit Margin | 2.06% |
| Debt/Equity Ratio | 21.9% |
How did SECARE perform over the long term?
See historical performance and comparisonDividends
Does SECARE pay a reliable dividends?
See SECARE dividend history and benchmarks| Swedencare dividend dates | |
|---|---|
| Ex Dividend Date | Apr 24 2026 |
| Dividend Pay Date | Apr 30 2026 |
| Days until Ex dividend | 27 days |
| Days until Dividend pay date | 33 days |
Does SECARE pay a reliable dividends?
See SECARE dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/27 20:23 |
| End of Day Share Price | 2026/03/27 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Swedencare AB (publ) is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Johan Brown | ABG Sundal Collier Sponsored |
| Adela Dashian | Jefferies LLC |
| Adrian Elmlund | Nordea Markets |